Reza Mostofi, M.D.
Dr. Mostofi was born in Iran and moved to the San Francisco Bay Area at a young age. He studied biological sciences with an emphasis in neuroscience, physiology and behavior at University of California Davis. He received his medical degree from St. George's University School of Medicine and went on to complete his internal medicine residency and hematology and oncology fellowship at Drexel University College of Medicine in Philadelphia. He served as chief fellow during his final year.
Dr. Mostofi brings more than a decade of oncology experience to City of Hope. He served as assistant professor of medicine at Temple University School of Medicine for over three years during his time at Crozer Regional Cancer Center, a Fox Chase Cancer Center affiliate. Well-versed in all malignancies, he is particularly drawn to the treatment of multiple myeloma, as well as lung, colon and breast cancer.
South Bay
Torrance, CA 90503
2010, American Board of Internal Medicine - Hematology
2009, American Board of Internal Medicine - Oncology
2006, American Board of Internal Medicine
2003, M.D., St. George's University School of Medicine, St. George’s, Grenada
1998, B.S., Biological Sciences, University of California Davis, Davis, California
2008-2009, Chief Fellow, Department of Hematology and Oncology, Drexel University College of Medicine / Hahnemann University
Hospital, Philadelphia, Pennsylvania2006-2009, Department of Hematology and Oncology, Drexel University College of Medicine / Hahnemann University Hospital, Philadelphia, Pennsylvania
2003-2006, Internal Medicine, Drexel University College of Medicine / Hahnemann University Hospital, Philadelphia, Pennsylvania
2020 - present, Assistant Clinical Professor, Medical Oncology & Therapeutics Research, City of Hope, South Bay, Torrance, CA
2013 - 2020, Physician, The Oncology Institute of Hope and Innovation, Torrance & Lynwood, CA
2009 - 2013, Physician, Associates in Hematology-Oncology, Upland, PA
2006 - 2009, Hospitalist and Moonlighter, Cancer Treatment Centers of America, Philadelphia, PA
2013, Philadelphia area’s Main Line Today Magazine “Top Doctors 2013”
2006-Present, American Society of Clinical Oncology
2006-Present, American Society of Hematology
- ChakuntaHR, Sunderkrishnan R, Kaplan MA, Mostofi R. Cholangiocarcinoma: Treatment with Sorafenib extended life expectancy to greater than four years, Journal of Gastrointestinal Oncology, May 13, 2013 DOI: 10.3978/j.issn.2078-6891.2013.031